HCW Biologics Inc.
HCWB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $16 | $7 | $5 | $395 |
| % Growth | 138.3% | 29.3% | -98.7% | – |
| Cost of Goods Sold | $186 | $5 | $4 | $316 |
| Gross Profit | -$171 | $1 | $1 | $79 |
| % Margin | -1,094.3% | 20% | 20% | 20% |
| R&D Expenses | $1,289 | $1,227 | $1,479 | $1,050 |
| G&A Expenses | $0 | $2,077 | $154 | $1,587 |
| SG&A Expenses | $1,827 | $2,077 | $154 | $1,587 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $161 | $334 | $602 |
| Operating Expenses | $3,115 | $3,465 | $1,967 | $3,239 |
| Operating Income | -$3,286 | -$3,464 | -$1,966 | -$3,160 |
| % Margin | -21,056.8% | -52,886.7% | -38,811.5% | -800.3% |
| Other Income/Exp. Net | -$1,268 | $1,536 | -$231 | -$214 |
| Pre-Tax Income | -$4,554 | -$1,928 | -$2,197 | -$3,373 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,554 | -$1,928 | -$2,197 | -$3,373 |
| % Margin | -29,183.2% | -29,431% | -43,373.6% | -854.4% |
| EPS | -2.02 | -6.79 | -0.05 | -0.08 |
| % Growth | 70.3% | -13,480% | 37.5% | – |
| EPS Diluted | -2.02 | -6.79 | -0.05 | -0.08 |
| Weighted Avg Shares Out | 2,260 | 1,780 | 44,676 | 38,793 |
| Weighted Avg Shares Out Dil | 2,260 | 1,780 | 44,676 | 38,793 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $127 | $229 | $256 | $248 |
| Depreciation & Amortization | $174 | $292 | $419 | $683 |
| EBITDA | -$4,253 | -$1,305 | -$1,249 | -$1,915 |
| % Margin | -27,254.7% | -19,921.4% | -24,659.1% | -485.1% |